Neurology News

CHICAGO — Environmental chemical exposure is a risk factor for neurodegenerative diseases and neurodevelopmental disorders, an expert at the 2022 American Neurological Association annual meeting said.

In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting.

CHICAGO — While population and phenotypic diversity are crucial to discovering the root cause of genetic variations that lead to neurodegenerative disease, the answers are not always clear, according to a presenter at ANA 2022.

CHICAGO — ANA president-elect M. Elizabeth Ross, MD, PhD, discusses highlights from her presentation on three-dimensional cultures of brain organoids at the 2022 American Neurological Association’s annual meeting.

CHICAGO – Deanna Saylor, MD, MHS, discussed how certain infectious diseases can lead to neurological complications in a presentation at the 2022 American Neurological Association meeting.

CHICAGO – For persons with epilepsy, cognitive impairment was reduced for those with the generalized form of the disease, as well as for those who are prescribed more than one type of therapy, according to a poster at ANA 2022.

CHICAGO – Rates of reaction times were slower among individuals who had long COVID compared with healthy counterparts, a researcher showed in a poster presentation at the 2022 American Neurological Association meeting.

CHICAGO – An app-based cognitive assessment tool set baseline scores for college football players and may be useful in rapid sideline concussion diagnosis, according to a poster at the 2022 American Neurological Association meeting.

Nearly two-thirds of patients with rheumatoid arthritis meet the criteria for at least one sleep disorder, according to data published in Arthritis Care & Research.

CHICAGO — With more than 1.5 million veterans diagnosed with headache over the past two decades, the Veterans Health Administration must improve outreach and care to address disparities, an expert said at ANA 2022.